Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 437 | 486 | 698 | 1,127 | 692 |
| TOTAL | $484 | $568 | $829 | $1,205 | $769 |
| Non-Current Assets | |||||
| Intangibles | 274 | 314 | 353 | 392 | 431 |
| TOTAL | $274 | $314 | $353 | $392 | $431 |
| Total Assets | $758 | $882 | $1,182 | $1,597 | $1,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 393 | 324 | 249 | 325 | 402 |
| TOTAL | $1,473 | $391 | $304 | $369 | $431 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 1,000 | 1,000 | 1,946 | 1,000 |
| TOTAL | $N/A | $1,000 | $1,000 | $1,000 | $1,000 |
| Total Liabilities | $1,473 | $1,391 | $1,304 | $1,369 | $1,431 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54 | 41 | 41 | 41 | 41 |
| Common Shares | 20 | 20 | 20 | 20 | 20 |
| Retained earnings | -190,212 | -190,006 | -189,619 | -189,266 | -189,725 |
| TOTAL | $-715 | $-509 | $-122 | $228 | $-231 |
| Total Liabilities And Equity | $758 | $882 | $1,182 | $1,597 | $1,200 |